• Vaxil Locations
  • Contact Us
  • Subscribe
Vaxil Bio
  • About Vaxil
  • TEAM
  • INTELLECTUAL PROPERTY
  • News and Updates
  • In the Media
07 Mar
Annnouncements

VAXIL PROVIDES UPDATE ON RESEARCH ACTIVITIES

… Read the rest
Posted on March 7, 2022March 7, 2022 by Gadi Levin
08 Feb
Annnouncements

VAXIL’S ANNUAL AND SPECIAL SHAREHOLDERS MEETING

… Read the rest
Posted on February 8, 2022February 16, 2022 by Gadi Levin
04 Jan
Annnouncements

VAXIL PROVIDES FINAL RESULTS ON ITS PREVIOUSLY DISCLOSED RESEARCH WITH BEN-GURION UNIVERSITY OF THE NEGEV

… Read the rest
Posted on January 4, 2022January 7, 2022 by Gadi Levin
13 Dec
Annnouncements

VAXIL ANNOUNCES RESIGNATION OF DIRECTOR

… Read the rest
Posted on December 13, 2021December 16, 2021 by Gadi Levin
14 Oct
Annnouncements

VAXIL SIGNS LETTER OF INTENT TO ACQUIRE A 100% INTEREST IN SHORT WAVE PHARMA INC.

… Read the rest
Posted on October 14, 2021October 22, 2021 by Gadi Levin
Older posts

Vaxil Canada
First Canadian Place, 34th Floor, 100 King Street W., Toronto, Ontario. M2N 6N4 Canada

Vaxil Israel
3 Pinhas Sapir Street, 3rd Floor, Weizmann Science Park, 74140, Rehovot, Israel

Corporate

  • Home
  • About Vaxil
  • Vaxil Locations
  • Contact Us
  • Board & Executives
  • News and Updates

INVESTORS

  • Investor Presentations
  • Public Filings
  • News and Updates
  • In the Media
  • Video
  • Scientific Publications
Copyright 2023 © VAXIL BIO THERAPEUTICS | Vaxil Bio therapeutics is an Israeli biotech focused on cancer immunotherapy, based in the Weizmann Science Park in Rehovot, Israel. Vaxil is listed on the TSX-Venture as VXL
  • About Vaxil
  • TEAM
  • INTELLECTUAL PROPERTY
  • News and Updates
  • In the Media
  • Vaxil Locations
  • Contact Us
  • Subscribe